Companies / Plus Therapeutics, Inc.
Plus Therapeutics, Inc.
Financials ยท FY2025
Ownership
6.9M shares outstanding ยท as of May 13, 2026
Ownership
| Insiders | 12.71% | 875,013 |
| Institutions | 156.30% | 10,758,444 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding โ public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all โ| Insider | % of shares | Shares |
|---|---|---|
Hedrick Marc HCEOChief Executive Officer ยท Director | 10.19% | 701,100 |
Sims Andrew John Hugh MacIntyreChief Financial Officer | 2.53% | 173,913 |
Andrews Ronald AsburyDirector | โ | โ |
Clowes HowardDirector | โ | โ |
Daniels Eric JosephChief Development Officer | โ | โ |
Guse KyleDirector | โ | โ |
Hawkins Richard JDirector | โ | โ |
van Es-Johansson AnDirector | โ | โ |
Institutional holders 28
View all โ| Holder | Value | % of shares |
|---|---|---|
| $1.17M | 33.12% | |
| $1.17M | 33.09% | |
| $524.5K | 14.88% | |
| $448.4K | 12.72% | |
| $419.4K | 1.39% | |
| $328.0K | 29.29% | |
| $240.2K | 6.81% | |
| $150.3K | 4.26% | |
| $127.3K | 3.61% | |
| $94.8K | 2.69% |
Activity
Jun 30, 2026View all โ
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares ฮ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Exit | Common stock | $-910.0K | -1.8M -100.00% | 0 | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | New | Common stock | $419.4K | +96K | 95,983 1.39% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Exit | Common stock | $-240.2K | -469K -100.00% | 0 | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common stock | $99.8K | +614K +43.74% | 2,016,314 29.29% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common stock | $44.2K | +272K | 271,599 3.95% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Exit | Common stock | $-1.0K | -1K -100.00% | 0 | low |
| Q1 2025 as of | Barclays PLC 13F manager | New | Common stock | $987 | +1K | 1,039 0.02% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-331 | -937 -90.18% | 102 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| CVI Investments, Inc. | Passive13G | โ |
| CVI Investments, Inc. | Passive13G/A | โ |
| Highbridge Capital Management, LLC | Passive13G | โ |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PSTV | โ | 72941H509 |
| PSTV | โ | 72941H806 |